Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 55
  • Start Date: March 31, 2021
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 60
  • Start Date: February 2021
Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous Marzeptacog Alfa (Activated) For On Demand Treatment and Control of Bleeding Episodes in Subjects With Hemophilia A or Hemophilia B, With Inhibitors: The Crimson 1 Study
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 48
  • Start Date: January 1, 2021
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis in Patients With Haemophilia A
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Biological
  • Participants: 13
  • Start Date: November 3, 2020
Long-Term Follow-up of Subjects Who Were Treated With SB-318, SB-913, or SB-FIX, for Targeted Genome Editing Into the Albumin Gene in the Liver
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 15
  • Start Date: October 2020
Monitoring and Pharmacodynamics Effect of Recombinant Factor IX Fc in Severe Haemophilia B Patients: a Real-life Study
Clinical Trial
  • Status: Recruiting
  • Participants: 112
  • Start Date: June 18, 2020
An Observational Cohort Study of Long-Term Outcomes of Orthotopic Liver Transplantation in People With Hemophilia
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: June 1, 2020
Lentiviral FIX Gene Therapy for Hemophilia B
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 5
  • Start Date: April 21, 2020
The Effectiveness of Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients Switching From Previous Factor IX Treatment
Clinical Trial
  • Status: Recruiting
  • Participants: 200
  • Start Date: February 14, 2020
Screening/Observational Protocol to Determine Patient Eligibility for Inclusion in AAV Gene Therapy Clinical Trials (ECLIPSE)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 22
  • Start Date: January 16, 2020
Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Genetic
  • Participants: 9
  • Start Date: October 16, 2019
Gene Therapy for Chinese Hemophilia B With Adeno-associated Virus (AAV) Vector
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: September 12, 2019
A 24-month Prospective, Non-interventional, International, Multicentre Study to Describe the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B
Showing 1-12 of 44